Headlines about Neogen (NASDAQ:NEOG) have trended somewhat positive recently, Accern reports. The research group scores the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Neogen earned a media sentiment score of 0.20 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 44.3990138721477 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
These are some of the news headlines that may have effected Accern’s analysis:
A number of analysts recently weighed in on the stock. ValuEngine upgraded shares of Neogen from a “hold” rating to a “buy” rating in a research note on Monday, April 2nd. Zacks Investment Research lowered shares of Neogen from a “buy” rating to a “hold” rating in a research note on Thursday, March 29th. Stephens reiterated a “hold” rating and issued a $65.00 price target (up from $62.00) on shares of Neogen in a research note on Monday, March 26th. BidaskClub upgraded shares of Neogen from a “buy” rating to a “strong-buy” rating in a research note on Thursday, March 15th. Finally, Roth Capital set a $62.00 price target on shares of Neogen and gave the company a “hold” rating in a research note on Thursday, January 4th. Five analysts have rated the stock with a hold rating, one has assigned a buy rating and one has given a strong buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $65.25.
Neogen stock traded down $1.05 during mid-day trading on Friday, hitting $67.30. The company had a trading volume of 208,498 shares, compared to its average volume of 234,005. The firm has a market capitalization of $3,471.54, a P/E ratio of 78.26, a P/E/G ratio of 4.06 and a beta of 1.27. Neogen has a 1 year low of $44.63 and a 1 year high of $68.69.
Neogen (NASDAQ:NEOG) last announced its quarterly earnings results on Thursday, March 22nd. The company reported $0.32 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.24 by $0.08. The company had revenue of $95.90 million for the quarter, compared to analyst estimates of $97.93 million. Neogen had a net margin of 14.82% and a return on equity of 11.49%. The firm’s revenue was up 8.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.27 earnings per share. sell-side analysts predict that Neogen will post 1.14 earnings per share for the current year.
In other news, CFO Steven J. Quinlan sold 2,000 shares of the stock in a transaction that occurred on Wednesday, February 21st. The stock was sold at an average price of $60.15, for a total value of $120,300.00. Following the completion of the sale, the chief financial officer now directly owns 15,470 shares of the company’s stock, valued at $930,520.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider James L. Herbert sold 25,334 shares of the stock in a transaction that occurred on Wednesday, February 21st. The shares were sold at an average price of $59.32, for a total value of $1,502,812.88. Following the completion of the sale, the insider now directly owns 1,157,591 shares of the company’s stock, valued at $68,668,298.12. The disclosure for this sale can be found here. Insiders sold 77,382 shares of company stock valued at $4,645,383 over the last three months. Corporate insiders own 4.20% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Neogen (NASDAQ:NEOG) Earns Coverage Optimism Rating of 0.20” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this story on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this story can be read at https://www.dispatchtribunal.com/2018/04/08/neogen-neog-getting-somewhat-positive-press-coverage-report-finds.html.
Neogen Company Profile
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells.
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.